- Tytuł:
- Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
- Autorzy:
- Źródło:
- In European Journal of Cancer February 2024 198
Czasopismo naukowe